ROBERT D. HOELDTKE, M.D., Ph.D.; GUENTHER BODEN, M.D.; CHARLES R. SHUMAN, M.D.; OLIVER E. OWEN, M.D.
The cause of the susceptibility of certain diabetic patients to severe hypoglycemia is not known. Because the awareness of hypoglycemia is heightened by catecholamine-mediated physiologic responses, deficient catecholamine secretion may cause frequent and severe hypoglycemia. Plasma epinephrine and norepinephrine were measured after insulin-induced hypoglycemia in 18 diabetic patients, nine with autonomic neuropathy, and in nine normal volunteers. Our results show that two thirds of patients with diabetic autonomic neuropathy have moderate to severe deficits in epinephrine secretion and that these patients have diminished or delayed subjective responses to low blood sugar and are at risk for developing severe hypoglycemia and its neurologic consequences.
Learn more about subscription options.
Register Now for a free account.
HOELDTKE RD, BODEN G, SHUMAN CR, OWEN OE. Reduced Epinephrine Secretion and Hypoglycemia Unawareness in Diabetic Autonomic Neuropathy. Ann Intern Med. 1982;96:459–462. doi: 10.7326/0003-4819-96-4-459
Download citation file:
Published: Ann Intern Med. 1982;96(4):459-462.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Neurology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only